ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track
November 24, 2020ARCA biopharma, Inc., a company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, received Fast Track designation from the FDA for AB201 as a potential treatment for COVID-19. -
ARCA biopharma submits IND application to US FDA for a potential COVID-19 treatment
September 22, 2020Pending FDA feedback, ARCA anticipates initiating the Phase 2b portion of a sequential Phase 2b/3 clinical evaluation of AB201 in the fourth quarter of this year.
Pharma Sources Insight January 2025
